AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (August 21, 2007). doi:10.1152/ajpendo.00279.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/5/E1224    most recent
00279.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horner, K. C
Right arrow Articles by Sauze, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horner, K. C
Right arrow Articles by Sauze, N.
Submitted on May 3, 2007
Accepted on August 10, 2007

Experimental estrogen-induced hyperprolactinemia results in bone-related hearing loss in the guinea pig

Kathleen C Horner1*, Yves Cazals2, Regis Guieu3, Marc Lenoir4, and Nicole Sauze5

1 Univ Paul Cezanne, CNRS UMR 6153, Marseille , France
2 Univ Paul Cezanne, CNRS UMR 6153, Marseille cedex 20, France
3 Univ Mediterranee, CNRS FRE 2738, Marseille cedex 20, France
4 INM, Inserm U583, Montpellier, France
5 Univ Mediterranee, CNRS FRE 2738, Marseille, cedex 20, France

* To whom correspondence should be addressed. E-mail: kathleen.horner{at}univ-cezanne.fr.

We have earlier described hyperprolactinemia in some patients presenting inner ear dysfunction. However, in that study it was not possible to determine whether hyperprolactinemia was a cause or an effect of the symptoms. In order to investigate the effect of hyperprolactinemia on inner ear function we first developed the model of hyperprolactinemia in estrogen-primed Fischer 344 rats and then performed functional studies on pigmented guinea pigs. Hyperprolactinemia induced, after two months, a hearing loss of around 30-40 dB across all frequencies as indicated by the compound action potential audiogram. During the third month the hearing loss continued to deteriorate. The threshold shifts were more substantial in males than females. Observations under the dissection microscope revealed bone dysmorphology of the bulla as well as the cochlea. Light microscopy observations of cryostat sections confirmed bone-related pathology of the bony cochlear bulla and the cochlear wall and revealed morphopathology of the stria vascularis and spiral ligament. Scanning electron microscopy revealed loss of hair cells and stereocilia damage, in particular, in the upper three cochlear turns and the two outermost hair cell rows. The data provide the first evidence of otic capsule and hair cell pathology associated with estrogen-induced prolonged hyperprolactinemia and suggests that conditions such as pregnancy, anti-psychotic drug treatment, aging and/or stress might lead to similar ear dysfunctions.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.